Drug Approval | December 28, 2021
India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod
It plans to deliver over 300 million doses to the Indian government
It plans to deliver over 300 million doses to the Indian government
Up to 100 million mRNA vaccine doses could be produced in Australia each year
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
Two out of three people under the age of 40 are at risk of prediabetes
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The company performed particularly well in operational eco-efficiency, environmental and social reporting
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
Biocon Biologics and Viatris co-developed the products
Subscribe To Our Newsletter & Stay Updated
